Home > Financial Ratios > NURECA

NURECA
Core EBITDA Margin

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NURECA
Please provide your vote to see the results

NURECA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -6.40-10.23-12.8720.5527.36

What is the latest Core EBITDA Margin ratio of NURECA ?

The latest Core EBITDA Margin ratio of NURECA is -6.40 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-6.40
Mar2024-10.23
Mar2023-12.87
Mar202220.55
Mar202127.36

How is Core EBITDA Margin of NURECA Trending?

Years Core EBITDA Margin % Change
Mar2025 -6.4
Negative
Mar2024 -10.23
Negative
Mar2023 -12.87
Negative
Mar2022 20.55
-24.89
Mar2021 27.36 -

Other Financial Ratios of NURECA


Compare Core EBITDA Margin ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹225.0 Cr 1.8% -12.2% -19.4% Stock Analytics
LENSKART SOLUTIONS ₹86,805.6 Cr -0.8% 5.2% NA Stock Analytics
POLY MEDICURE ₹15,330.1 Cr 3.8% -0.4% -32.7% Stock Analytics
LAXMI DENTAL ₹1,244.1 Cr 0.8% 11.7% -44.1% Stock Analytics
3B BLACKBIO DX ₹1,101.0 Cr 6.3% -6.4% -22.8% Stock Analytics
PREVEST DENPRO ₹458.4 Cr 3.8% -5.6% -19.3% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

1.8%

-12.2%

-19.4%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses